Palisade Bio (PALI) Debt to Equity (2016 - 2025)
Palisade Bio has reported Debt to Equity over the past 11 years, most recently at $0.07 for Q3 2025.
- Quarterly Debt to Equity changed N/A to $0.07 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $0.07 through Sep 2025, changed N/A year-over-year, with the annual reading at $0.01 for FY2023, N/A changed from the prior year.
- Debt to Equity was $0.07 for Q3 2025 at Palisade Bio, up from $0.03 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.07 in Q3 2025 and troughed at -$0.12 in Q2 2021.
- The 4-year median for Debt to Equity is $0.01 (2024), against an average of $0.01.
- Year-over-year, Debt to Equity skyrocketed 117.19% in 2021 and then dropped 8.91% in 2025.
- A 4-year view of Debt to Equity shows it stood at $0.01 in 2021, then grew by 7.01% to $0.01 in 2023, then increased by 18.48% to $0.01 in 2024, then soared by 388.52% to $0.07 in 2025.
- Per Business Quant, the three most recent readings for PALI's Debt to Equity are $0.07 (Q3 2025), $0.03 (Q2 2025), and $0.01 (Q1 2025).